Sign in
Not yet recruitingPhase 3

MAGNEFFICIENT: A prospective, randomized, double-blind, placebo-controlled, single-center clinical trial.

Key facts

Who runs it
Henry Dunant Hospital Center
Where
Greece1 site in 1 countryChoose a country to see its sites
Status
Not yet recruiting
Phase
Phase 3
People taking part
500 people, planned
Started
1 Sept 2025
Expected to end
1 Mar 2028
Type of study
Interventional
Record updated
22 October 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Adults aged 18–90 years scheduled for total thyroidectomy
  • With or without lymph node dissection, for any benign or malignant indication
  • Able to provide written informed consent
  • No history of parathyroid disorder or calcium/magnesium metabolism disorder

Who cannot take part

  • Active malabsorption syndromes
  • Renal insufficiency (eGFR <60 mL/min)
  • Current or chronic use of magnesium supplementation
  • Medications affecting calcium/magnesium (e.g., diuretics)
  • Known intolerance to magnesium therapy
  • Patients with comorbidities potentially exacerbated by magnesium supplementation, including: • Cardiac arrhythmias (e.g., AV block, bradyarrhythmias) • Myasthenia gravis • Severe gastrointestinal disorders affecting absorption (e.g., active IBD) • History of hypermagnesemia or magnesium toxicity • Concurrent use of medications with known magnesium interactions (e.g., aminoglycosides, digoxin, bisphosphonates, proton pump inhibitors)
  • Pre-existing hypoparathyroidism or hyperparathyroidism
  • Unwillingness to comply with study visits or procedures

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

To determine whether 8-day oral magnesium aspartate (243 mg/day) reduces chronic postoperative hypoparathyroidism at 6 months.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Official title
The "MAGNEFFICIENT" Prospective Trial: Preoperative Administration of MAGNesium for EFFICIENT Parathyroids after Thyroidectomy
Record updated
22 October 2025